Updated hourlyHourly refreshSat, Sep 19, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
(PR-inside.com) OMCAZIO approved for administration without regard to food, removing strict fasting requirements for cabozantinib patients SAN JOSE, CA AND TAIPEI, TW / ACCESS Newswire / September 11, 2026 / Handa Pharmaceuticals, Inc. ("Handa" or the "Company") (TSE:6620) announced that the U.S. Food and Drug Administration ("FDA") has granted final approval to OMCAZIO™ (cabozantinib) capsules, the laurylsulfate salt formulation of cabozantinib developed by the Company's U.S. subsidiary, Handa Oncology, LLC. The action converts Handa's prior tentative approval to final approval and authorizes OMCAZIO for commercialization in the United States. "Final approval from the FDA is a landmark milestone for Handa and reflects our ..
Sep 11 · 11:30·PR-Inside
Healthcare
Shanghai, China--(Newsfile Corp. - September 11, 2026) - On August 4, the 20th Frost & Sullivan Global Growth, Innovation and Leadership (GIL) Summit and the 5th New Investment Event (the "2026 Frost & Sullivan New Investment Event") officially opened at Jing An Shangri-La, Shanghai.In conjunction with the Summit, the Celebratory Banquet for the 65ᵗʰ Anniversary of Frost & Sullivan Global and the 20ᵗʰ Anniversary of the GIL Summit in China was held, where the 2026 Frost & Sullivan Global Awards...
Sep 11 · 11:28·mlpr-newsfile
Healthcare
A pharmaceutical product cannot reach the patient safely through formulation alone. Before a tablet, vaccine, biologic, or injectable reaches the market, it must pass through [read full press release...]
Sep 11 · 11:25·Express Press Release
Finance · Healthcare
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 11, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ:GUTS) securities. If you suffered a loss on your Fractyl Health, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fractyl Health, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
Sep 11 · 11:25·PR-Inside
Finance · Healthcare
(PR-inside.com) Access the video webcast here IRVINE, CA / ACCESS Newswire / September 11, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that its pre-recorded presentation from the H.C. Wainwright 28th Annual Global Investment Conference is now available for on-demand viewing here. The presentation, featuring Robert Berman, Chief Executive Officer of enVVeno Medical, provides an overview of the Company and its innovative enVVe® System, as well as recent corporate and clinical developments. The on-demand presentation is available for viewing beginning today, September 11, 2026, at 7:00 a.m. ET, and can be accessed through the Events page on the Investors ..
Sep 11 · 11:02·PR-Inside
Healthcare
New York Health (NY Health) proudly announces the addition of Dr. Myrta Isabel Olivera-Dubón, a board-certified family medicine physician dedicated to providing comprehensive, evidence-based care. Beginning September 8, 2026, Dr. Olivera-Dubón will be practicing at NY Health’s office located at 1377 5th Ave, Bay Shore, NY 11706. “We are excited to welcome Dr. Olivera-Dubón to our [PR.com]
Sep 11 · 11:01·PR.com
Finance · Healthcare
WILMINGTON, Del., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the H.C. Wainwright 28 th Annual Global Investment Conference, taking place in New York City September 14-16, 2026.
Sep 11 · 11:01·GlobeNewswire
Finance · Healthcare
WILMINGTON, Del., Sept. 11, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, today announced that its subsidiary, HOPE Therapeutics, Inc. ("HOPE"), will be the first Interventional Psychiatry to deploy Zeta Surgical's newly FDA-cleared Zeta TMS Robotic System, with clinical staff now in training ahead of deployment in Florida.
Sep 11 · 11:00·GlobeNewswire
AI · Healthcare
Abstract submissions are open for NURSING-2027, the 4th International Conference on Nursing and AI-Driven Digital Healthcare, set for July 12–13, 2027, in Hamburg, Germany.
Sep 11 · 09:50·PressReleaseNews
Finance · Healthcare
(PR-inside.com) BOULDER, CO / ACCESS Newswire / September 11, 2026 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced that on September 8, 2026 it completed an $80,000 private placement of common stock with a group of private investors. "We are pleased to have secured necessary funds for general working capital purposes," said Robert Fries, Interim President and CEO of Encision. Pursuant to the securities purchase agreement, the Company issued 2 million common shares at a per share price of $0.04 per common ..
Sep 11 · 09:00·PR-Inside
Healthcare
PUBLICHEALTH-2027, the 2nd International Conference on Public Health and Health Care System, will take place April 19–20, 2027, in Milan, Italy, gathering global health stakeholders to address emerging public health priorities.
Sep 11 · 08:49·PressReleaseNews
Healthcare
Healthcare packaging is quietly becoming one of the most demanding corners of the materials industry. As drug and device makers push toward smaller, more sensitive, [read full press release...]
Sep 11 · 08:29·Express Press Release